Add this topic to your myFT Digest for news straight to your inbox
CEO hoped simplifying dual-headquarters structure would cap his 10-year tenure
Chairman Marijn Dekkers defends company’s proposal to move HQ to Netherlands
ISS raises concerns over switch to consolidated ‘fixed pay’ structure
After a bid attempt, the inclination to overreact needs to be resisted
New chief executive faces pressure to jump-start growth
Drugmaker confirms Dekkers’ departure as consumer group says he is set succeed Michael Treschow
Company veteran and heir apparent Werner Baumann is set to take reigns from Marijn Dekkers
Chief comments likely to fuel speculation of tie-up for Syngenta’s vegetable seed business
The one-time tennis prospect on running a €90bn life sciences group without burning out
German group to proceed with listing of materials arm with analysts pointing to €10bn-plus valuation
German group is also to buy consumer drugs as it shifts away from chemicals industry past
German group shifts toward life sciences
The new head of the Swiss drugs group is adopting a different leadership style
International Edition